Oncology Pharmacy

The BPS Board Certified Oncology Pharmacist (BCOP) program is a credential for pharmacists who have met the eligibility criteria below and who in their unique practice, involving an increasing number and complexity of drug therapies for treating and preventing cancer, manage cancer-related and drug-related adverse events or clinical situations not encountered in other disease states.

The purpose of the BCOP program is to validate that the pharmacist has the advanced knowledge and experience to optimize outcomes for patients with malignant diseases by:

  • Recommending, designing, implementing, monitoring, and modifying pharmacotherapeutic plans.
  • Reducing medication errors.
  • Recognizing and responding to adverse physical and emotional issues that may arise during treatment and when providing education and counseling.

BPS Oncology Pharmacy Brochure

Eligibility Requirements (all practice eligibility requirements must be met prior to the candidate sitting for the examination)

The minimum requirements for this specialty certification are:

  • Graduation from a pharmacy program accredited by the Accreditation Council for Pharmacy Education (ACPE) or a program outside the U.S. that qualifies the individual to practice in the jurisdiction.
  • Current, active license to practice pharmacy in the U.S. or another jurisdiction.
  • Completion of four (4) years of practice experience (post-pharmacist licensure) with at least 50% of time spent in oncology pharmacy activities as defined by the Oncology Pharmacy Content Outline (Fall 2017 ). **Practice experience should be from within the past seven years prior to the application date. 
    OR
  • Completion of a PGY1 residency* plus two (2) additional years of practice (post-pharmacist licensure) with at least 50% of time spent in oncology pharmacy activities as defined by the Oncology Pharmacy Content Outline  (Fall 2017 ).  **Practice experience should be from within the past seven years prior to the application date.
    OR
  • Completion of a specialty (PGY2) residency* in oncology pharmacy.
  • Achieving a passing score on the Oncology Pharmacy Specialty Certification Examination.

*Effective January 1, 2013, only residency programs accredited by the American Society of Health-System Pharmacists (ASHP) and completed by the applicant within the past 7 years, or new residency programs granted Candidate Status for accreditation by ASHP are creditable for this purpose.

Examination Content – Spring 2017

(Refer to the Oncology Pharmacy Content Outline for details)

  • Domain 1: Patient Management and Therapeutics. (57% of the examination)
  • Domain 2: Research and Education. (22% of the examination)
  • Domain 3: Practice Administration and Development. (17% of the examination)
  • Domain 4: Public Health and Advocacy. (4% of the examination)

Examination Content – Fall 2017

(Refer to the Oncology Pharmacy Content Outline for details)

  • Domain 1: Pathophysiology and Molecular Biology of Cancer (20% percent of examination)
  • Domain 2: Therapeutics, Patient Management, and Education (38% percent of examination)
  • Domain 3: Clinical Trials and Research (14% percent of examination)
  • Domain 4: Practice Management (22% percent of examination)
  • Domain 5: Public Health (6% percent of examination)

Recertification

Recertification for Board Certified Oncology Pharmacists® (BCOP) requires assessment of a practitioner’s knowledge and skills through one of two methods:

A current, active license to practice pharmacy is required for recertification.

Board Certified Oncology Pharmacists® are also required to pay the BPS Annual Certification Maintenance fee of $125 each year for years one through six and a $400 recertification fee in year seven.

Individuals with more than one BPS certification will only be assessed one BPS Annual Certification Maintenance Fee each year.